Sep 16, 2026 06:55AM
Sep 15, 2026 08:01AM
Sep 15, 2026 08:00AM
Aug 12, 2026 06:56AM
Aug 10, 2026 08:00AM
Jun 30, 2026 08:00AM
Jun 30, 2026 08:00AM Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)
Jun 18, 2026 06:47AM
Jun 12, 2026 08:00AM
Jun 12, 2026 08:00AM
Jun 1, 2026 07:31AM
Jun 1, 2026 06:57AM
May 30, 2026 08:00AM
May 30, 2026 08:00AM Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clini
May 28, 2026 08:01AM
May 28, 2026 08:00AM
May 5, 2026 08:00AM
Apr 2, 2026 06:45AM
Apr 1, 2026 08:02AM
Apr 1, 2026 08:00AM
Mar 16, 2026 09:57AM Raymond James Reiterates Strong Buy Rating on Cogent (COGT)
Mar 16, 2026 08:02AM
Mar 16, 2026 08:00AM
Feb 17, 2026 08:00AM
Feb 10, 2026 08:00AM
Jan 26, 2026 08:02AM
Jan 26, 2026 08:00AM
Jan 20, 2026 08:02AM FDA agrees to review Cogent's bezuclastinib application for rare cancer
Jan 20, 2026 08:00AM
Jan 14, 2026 06:54AM
Jan 12, 2026 03:47PM
Jan 12, 2026 08:07AM
Jan 12, 2026 08:00AM
Jan 7, 2026 12:41AM
Jan 6, 2026 06:42AM Cogent (COGT) PT Raised to $52 at H.C. Wainwright
Dec 30, 2025 08:02AM
Dec 30, 2025 08:00AM
Dec 8, 2025 07:31AM
Dec 8, 2025 07:30AM
Dec 8, 2025 02:54AM
Dec 6, 2025 09:30AM
Nov 10, 2025 01:18PM Cogent (COGT) PT Raised to $50 at Leerink Partners
Nov 10, 2025 07:00AM
Nov 10, 2025 07:00AM
Nov 3, 2025 09:01AM
Oct 24, 2025 12:30PM
Oct 24, 2025 12:30PM
Oct 24, 2025 08:29AM
Oct 20, 2025 08:32AM Cogent Biosciences receives FDA breakthrough therapy designation
Oct 20, 2025 08:32AM

334,267 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All